AngioSoma, Inc. Company Profile

11:15 EST 23rd January 2019 | BioPortfolio

News Articles [3 Associated News Articles listed on BioPortfolio]

AngioSoma Launches a New Suite of Products Formulated for Men and Women, Morning and Night

AngioSoma (OTC: SOAN) announces today the development of a new and improved version of its popular StemStrength™ formula. Original StemStrength™ was designed for men only but ...

AngioSoma Announces New Ecommerce Platform Featuring Innovative Products

AngioSoma (OTC: SOAN) announced today the launch of their new ecommerce site for its retail brand, SomaCeuticals™. The site,, features products within the...

AngioSoma to Organize Business to Enhance Future Success

New Business Units Created to Focus Resources on Growth Opportunities AngioSoma (OTC: SOAN) today announced they will organize the business into three new business units to me...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "AngioSoma, Inc." on BioPortfolio

We have published hundreds of AngioSoma, Inc. news stories on BioPortfolio along with dozens of AngioSoma, Inc. Clinical Trials and PubMed Articles about AngioSoma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AngioSoma, Inc. Companies in our database. You can also find out about relevant AngioSoma, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record